SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)

Italy flag Italy · Delayed Price · Currency is EUR
18.60
+0.48 (2.65%)
At close: Dec 4, 2025
-26.77%
Market Cap 2.56B
Revenue (ttm) 975.68M
Net Income (ttm) 146.87M
Shares Out n/a
EPS (ttm) 0.97
PE Ratio 17.43
Forward PE 16.61
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 94
Open n/a
Previous Close 18.12
Day's Range n/a
52-Week Range 17.86 - 30.40
Beta n/a
RSI 40.26
Earnings Date Dec 11, 2025

About BIT:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. It offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,690
Stock Exchange Borsa Italiana
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In 2024, BIT:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.

Financial Statements

News

There is no news available yet.